Trevi Therapeutics Inc (NASDAQ:TRVI)
| 2.20 Delayed Data As of Sep 29 |  -0.075 / -3.30%Today’s Change | 1.43 Today|||52-Week Range 3.50 | +13.99% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | -- | |||
| Operating Activities | Net Income / Starting Line | -11.1M | -12.9M | -20.5M | -- | |
| Depreciation | 4.0K | 4.0K | 23.0K | -- | ||
| Total Other Cash Flow | 1.4M | 4.2M | 2.8M | -- | ||
| Funds From Operations | -9.7M | -8.7M | -17.7M | -- | ||
| Funds From/For Other Operating Expenses | 1.5M | -762.0K | 601.0K | -- | ||
| Net Cash Flow - Operating Activities | -11.2M | -7.9M | -18.3M | -- | ||
| Investing | Capital Expenditures | 0.00 | -13.0K | -158.0K | -- | |
| Net Cash Flow Investing | 0.00 | -13.0K | -158.0K | -- | ||
| Financing | Short Term Borrowings | 10.5M | 29.9M | 10.5M | -- | |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | -- | -- | |
| Long Term Debt Reduction | -1.9M | -8.3M | -5.3M | -- | ||
| Net Proceeds Stock Sale | 0.00 | 59.0K | -1.5M | -- | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | -- | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | -- | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | -- | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | -- | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | -- | -- | |
| Net Cash Flow - Financing | 8.6M | 21.7M | 3.6M | -- | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | -2.6M | 13.8M | -14.9M | -- | ||
